GENO.ST STO
Genovis AB
1W: +3.0%
1M: -9.1%
3M: +1.8%
YTD: -0.4%
1Y: -19.8%
3Y: -55.9%
5Y: -65.0%
kr 19.54 ($1.94)
-0.14 (-0.71%)
Weekly Expected Move ±4.8%
kr 18
kr 19
kr 20
kr 20
kr 21
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$32M
-13.7% ▼
5Y CAGR: +53.5%
Capital Expenditures
$32M
-2845.9% ▼
5Y CAGR: +9.4%
Free Cash Flow
$0
-100.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-113.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $25M | $8M | $62M | $33M | $23M |
| Depreciation & Amort. | $6M | $7M | $10M | $0 | $12M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $16M | -$15M | $3M | $11M | -$523K |
| Other Non-Cash Items | -$151K | -$1M | -$7M | -$7M | -$3M |
| Operating Cash Flow | $46M | -$928K | $68M | $37M | $32M |
| — Investing Activities — | |||||
| Capital Expenditures | -$4M | -$4M | -$10M | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$3M | -$893K | -$2M | $14M | -$53M |
| Investing Cash Flow | -$4M | -$4M | -$13M | $14M | -$53M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$5M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$4M | -$4M | -$5M | $0 | $15M |
| Financing Cash Flow | -$4M | -$4M | -$5M | -$5M | $15M |
| Net Change in Cash | $37M | -$8M | $50M | $46M | -$6M |
| Cash End of Period | $81M | $73M | $123M | $169M | $163M |
| Free Cash Flow | $41M | -$5M | $55M | $37M | $0 |